HPRA, JAZMP inspect Divi’s Laboratories’ Unit-2 Vishakhapatnam

31 Aug 2019 Evaluate

Divi’s Laboratories’ Unit-2 Vishakhapatnam has been inspected by 5 inspectors from HPRA (Ireland) and JAZMP (Slovenia) from August 26, 2019 to August 30, 2019. The inspection at site was focused on general GMP. The inspection has concluded successfully with no critical observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

3385.55 49.05 (1.47%)
27-Jan-2023 18:01 View Price Chart
Company Name CMP
Sun Pharma Inds. 1043.60
Cipla 1047.05
Dr. Reddys Lab 4318.30
Lupin 742.20
Zydus Lifesciences 430.25
View more..